|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 19, 2017 ) According to the report Europe Radiotherapy Market, published by Market Data Forecast the Market was worth USD 1,362.5 million in 2016 and estimated to be growing at a CAGR of 5.71%, to reach USD 1,798.5 million by 2021. Markets such as Europe are ripening with both old and new technologies. The most often arising forms of the disease in the European region are colorectal, breast, prostate, and lung cancers.
Radiotherapy is a painless treatment and is extensively used in cancer treatment. Radiotherapy is centred on the principle of damage of cancerous cells by destructing their DNA inside these cells by radiations. It slow down the growth of cancerous cells and is intended at providing comforting care to relieve the patient of symptoms.
Browse market data tables and in-depth TOC of the Europe Radiotherapy Industry to 2021 @ http://www.marketdataforecast.com/market-reports/europe-radiotherapy-market-817/
The Europe radiotherapy market is driven by numeral factors like surge in the number of cancer patients, decrease in the cost of treatment in several developed areas, enormous government and non-government funds in Research and Development of cancer treatment and inclination for non-invasive techniques of treatment. In radiotherapy, harm to neighbouring healthy cells by the high dosage of radiation is a side-effect which could pose a risk for market growth. The several side-effects of radiation treatment such as fatigue, skin problems, nausea, fertility issues, hair loss, appetite loss, diarrhea could possibly obstruct radiotherapy devices market growth.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-radiotherapy-market-817/request-sample
The Europe radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-radiotherapy-market-817/inquire
Based on geography the market is analysed under various regions namely, Germany, France, Italy, Spain and U.K. France is expected to grow at highest CAGR among the countries in European region during the forecast period from 2016-2021.
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
